Navigating the rapidly changing oncology treatment landscape: how digital tools can help
May 2, 2024 | Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…
The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.
Specific challenges facing the oncology field
1. Increased competition and evolving standard of care
New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.
With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.
Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Powering Rapid Cognitive Analysis with AI
Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.
KOL Ambassador Program & Podcast Creation: A Customer Story
Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives…
Importance of Emotional Intelligence in Pharma and Medical Affairs
Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional…
Virtual product launch planning: the ultimate playbook
We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.
Artificial Intelligence for Identifying and Monitoring Cognitive Decline
Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.
Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic
While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear…
Navigating the Nuances of Europe’s MedTech Industry
Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and…
Pharma, Technology, and Healthcare in the New Normal
Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with…
Traversing the Medtech Regulatory Landscape in the Interest of Patients
Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting…
Scanning for Health Indicators and Risks Through Your Smartphone
Vlado Bosanac, Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging, dives into the implications of increased integration of tech and data into daily life for the…